Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07620574
Title field or adapter rule
{'original_value': 'Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:21.715738+00:00
Published At
2026-10-28T00:00:00+00:00
Record Updated At
2026-10-28
Source Retrieved At
2026-10-31T22:18:26.854673+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cancer", "Renal Cell Carcinoma (RCC)", "Pancreatic Neuroendocrine Tumors (pNET)", "Extra-Pancreatic NET (epNET)", "Hepatocellular Carcinoma (HCC)", "Differentiated Thyroid Cancer (DTC)", "Non-Clear Cell Renal Cell Carcinoma (nccRCC)", "Colorectal Cancer", "Prostate Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-28", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07620574"
protocolSection.identificationModule.officialTitle
"Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study"
protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Cancer (protocolSection.conditionsModule.conditions)
  • Renal Cell Carcinoma (RCC) (protocolSection.conditionsModule.conditions)
  • Pancreatic Neuroendocrine Tumors (pNET) (protocolSection.conditionsModule.conditions)
  • Extra-Pancreatic NET (epNET) (protocolSection.conditionsModule.conditions)
  • Hepatocellular Carcinoma (HCC) (protocolSection.conditionsModule.conditions)
  • Differentiated Thyroid Cancer (DTC) (protocolSection.conditionsModule.conditions)
  • Non-Clear Cell Renal Cell Carcinoma (nccRCC) (protocolSection.conditionsModule.conditions)
  • Colorectal Cancer (protocolSection.conditionsModule.conditions)
  • Prostate Cancer (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Cabozantinib/Zanzalintinib'], 'description': 'Administered as specified in the parent study.', 'name': 'Cabozantinib', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cabozantinib/Zanzalintinib'], 'description': 'Administered as specified in the parent study.', 'name': 'Zanzalintinib', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cabozantinib/Zanzalintinib'], 'description': 'Administered as specified in the parent study.', 'name': 'Atezolizumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cabozantinib/Zanzalintinib'], 'description': 'Administered as specified in the parent study.', 'name': 'Nivolumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cabozantinib/Zanzalintinib'], 'description': 'Administered as specified in the parent study.', 'name': 'Abiraterone', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cabozantinib/Zanzalintinib'], 'description': 'Administered as specified in the parent study.', 'name': 'Prednisone', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cabozantinib/Zanzalintinib'], 'description': 'Administered as specified in the parent study.', 'name': 'Enzalutamide', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Cabozantinib (protocolSection.armsInterventionsModule.interventions[].name)
  • Zanzalintinib (protocolSection.armsInterventionsModule.interventions[].name)
  • Atezolizumab (protocolSection.armsInterventionsModule.interventions[].name)
  • Nivolumab (protocolSection.armsInterventionsModule.interventions[].name)
  • Abiraterone (protocolSection.armsInterventionsModule.interventions[].name)
  • Prednisone (protocolSection.armsInterventionsModule.interventions[].name)
  • Enzalutamide (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.